The study found that Prequel ® Prenatal Screen with AMPLIFY™ technology enables reliable results as early as eight-weeks’ gestation. Typically, prenatal cell-free DNA (pcfDNA) screening is offered ...

Myriad Genetics, Inc. MYGN and Intermountain Precision Genomics, a service of Intermountain Health, recently secured the New York State Clinical Laboratory Permit to offer solid tumor testing to ...

SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...

Myriad Genetics, Inc. has launched a new educational ... pregnant women between 7-37 weeks gestational age. In a 2021 laboratory test, SneakPeek accurately determined fetal sex in 99.02% of ...

Myriad Genetics focuses on advancing health through genetic testing and aiding informed ... Myriad is acknowledged as one of the first commercial laboratories to market a multi-ancestry breast ...

combining high-performance MRD assays with efficient lab workflows and cutting-edge infrastructure. Furthermore, the Precise Liquid test, expected to be commercially launched by Myriad Genetics in ...

Myriad offers three genetic tests to those who are pregnant ... women between 7-37 weeks gestational age. In a 2021 laboratory test, SneakPeek accurately determined fetal sex in 99.02% of ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...

The renowned genetic testing and precision medicine ... Over the last three years, Myriad Genetics has invested over $75 million in state-of-the-art labs, standard-based technologies and digital ...